Form4insider filings, from the source

SEC Form 4 · accession 0001213900-18-015557

ADIAL PHARMACEUTICALS, INC. · ADIL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin Schuyler
Director · 10% Owner
Period of report
Nov 12, 2018
Accepted (ET)
Nov 13, 2018 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513525

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant to purchase unitsF1$5.00Nov 12, 2018J120,000DJul 31, 2018Jul 31, 2023Units240,0000D
Warrant to purchase common stockF1$5.00Nov 12, 2018J120,000ANov 12, 2018Jul 31, 2023Common Stock120,000120,000D
Warrant to purchase common stockF1$6.25Nov 12, 2018J120,000ANov 12, 2018Jul 31, 2023Common Stock120,000120,000D
Warrant to purchase unitsF2$5.00Nov 12, 2018J162,200DJul 31, 2018Jul 31, 2023Units324,4000I
Warrant to purchase common stockF2$5.00Nov 12, 2018J162,200ANov 12, 2018Jul 31, 2023Common Stock162,200162,200I
Warrant to purchase common stockF2$6.25Nov 12, 2018J162,200ANov 12, 2018Jul 31, 2023Common Stock162,200162,200I

Explanation of responses